OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Diabetes and Its Complications is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL/6J mice	108
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study	81
Impact of obesity on COVID-19 patients	74
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?	62
Role of ceramides in the pathogenesis of diabetes mellitus and its complications	56
Homocysteine and diabetes: Role in macrovascular and microvascular complications	49
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes	44
Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review	43
Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP	38
Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity	36
Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications	35
Post-COVID syndrome, inflammation, and diabetes	34
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes	34
Patient perspectives on the physical, psycho-social, and financial impacts of diabetic foot ulceration and amputation	34
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases	32
Depression and cardiovascular disease events among patients with type 2 diabetes: A systematic review and meta-analysis with bias analysis	32
From obesity to Alzheimer's disease through insulin resistance	32
Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes	32
Glycated albumin as biomarker: Evidence and its outcomes	31
Correction of anemia by dapagliflozin in patients with type 2 diabetes	31
A systematic review with meta-analysis of the impact of access and quality of diabetic foot care delivery in preventing lower extremity amputation	28
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases	27
Management of mitochondrial diabetes in the era of novel therapies	27
Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease	26
Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality	25

A review of biosensor technology and algorithms for glucose monitoring	25
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis	25